spacer
home > epc > spring 2002 > maintaining validation control over edc systems during a clinical study
PUBLICATIONS
European Pharmaceutical Contractor

Maintaining Validation Control Over EDC Systems During a Clinical Study

A lot has been written about the benefits of implementing electronic data capture (EDC) in the context of clinical studies. Topics commonly covered include the regulations, guidance and standards against which EDC solutions are created and implemented, the methods for maintaining data security, and those for measuring and delivering a return on investment, not to mention the general ways in which EDC affects and improves the processes of data gathering and what the future holds.

Despite the discussion about EDC there has been limited use of the technology throughout pharmaceutical companies' development pipelines. Whilst 50 per cent of companies may claim to have used EDC, this has commonly only been in pilot phase. This level of maturity is reflected in the industry estimates that EDC is still only used in between 5 per cent and 10 per cent of studies commenced on an annual basis (1).

Companies are grappling with the practical aspects of EDC implementation in a constantly changing environment. This situation presents particularly interesting challenges for the clinical research organisation (CRO) community. CROs find themselves either trying to implement a 'standard EDC solution' or deliver flexibility to their clients. Both approaches have their limiting factors. As the market matures, perhaps the latter approach best enables CROs to take advantage of the EDC technology which proves itself to satisfy the needs of their market segment.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Simon Crowe, Senior Business Development Manager, Informatics & Technology Services at PPD Development, UK

Simon Crowe has spent the last seven years working with clients in the manufacturing and pharmaceutical sectors. He has helped to specify and supply appropriate computing technology to meet the need for improved management of information. During this period Simon was responsible for all commercial aspects of a start-up EDC vendor, 4th Wave Technologies. Most recently Simon has taken on the role of Senior Business Development Manager at PPD Development.
spacer
Simon Crowe
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>

White Papers

Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies

PCI Pharma Services

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even more burdensome over the last several years as the industry pushes the boundaries of innovation. This is because newer, often more-complex therapies not only increase risk in drug development but also drive costs even higher. A recent analysis of the investment needed to develop a new prescription medicine shows the total cost can be as high as $2.6 billion (1). That number becomes even more staggering when you consider the fact that only about 12 percent of drug candidates that make it to Phase I testing are eventually approved by the FDA (2). The investment companies lose as a result may be too devastating to their bottom line to ever recover.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement